Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Celgene and Forma enter second collaboration; Celgene gets buy-out option

16 Dec 2022

Executive Summary

Celgene Corp. and drug discovery firm Forma Therapeutics Holdings LLC entered into their second partnership in just a year, this time teaming up for the discovery and development of compounds spanning a variety of therapeutic areas including cancer, with the potential for Celgene to buy Forma outright at the end of a possible seven-and-a-half year term.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes M&A Option
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By